check_circleStudy Completed
Contraception
Bayer Identifier:
15253
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Data on Oral Contraceptives Compliance in Non Stop Regimen
Trial purpose
Adherence to the dosing scheme is the principal element of COC efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.
Key Participants Requirements
Sex
FemaleAge
18 - 50 YearsTrial summary
Enrollment Goal
8416Trial Dates
May 2010 - November 2010Phase
N/ACould I Receive a placebo
NoProducts
Drospirenone (DRSP, BAY86-5131)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Poland |
Primary Outcome
- The percentage of users showing noncompliant behaviorsdate_rangeTime Frame:3 consecutive cycles (28-days per cycle)enhanced_encryptionNoSafety Issue:
Secondary Outcome
- The characteristics of noncompliant behavior.date_rangeTime Frame:3 consecutive cycles (28-days per cycle)enhanced_encryptionNoSafety Issue:
- The relation between noncompliant behavior and selected factors.date_rangeTime Frame:3 consecutive cycles (28-days per cycle)enhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A